Phase II study of dose escalation and concentration in stereotactic body radiotherapy (SBRT) for metastatic pulmonary or liver tumors from colorectal cancer
Not Applicable
Recruiting
- Conditions
- pulmonary or liver metastasis from colorectal cancer
- Registration Number
- JPRN-UMIN000026577
- Lead Sponsor
- Ofuna Chuo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Not provided
Exclusion Criteria
1.No apparent interstitial pneumonitis or fibrosis in patients with pulmonary metastasis 2.No liver cirrhosis more than Child-Pugh score 7 in patients with liver metastasis 3.No active inflammation except for using ointment 4.No multiple cancer (except for carcinoma in-situ) 5.No pregnancy or breast feeding 6.No psychiatric disorder 7.No steroid administration 8.No concurrent chemotherapy 9.No fever above 38 10.No cough with opioid drug 11.No other reason that clinician judged as improper
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method